Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Recher

Showing results (211-220 of 488) with videos related to

Pageof 49
Sort By:
Neurology|September 26, 2002
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MSD Brassat, C Recher, E Waubant, et al.
Plos One|January 23, 2025
zIncubascope: Long-term quantitative imaging of multi-cellular assemblies inside an incubatorAnirban Jana, Naveen Mekhileri, Adeline Boyreau, et al.
Archives of Cardiovascular Diseases|December 3, 2014
Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal OccluderFrançois Godart, Ali Houeijeh, Morgan Recher, et al.
Blood|May 22, 2009
Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cellsAnnelies G Renner, Cédric Dos Santos, Christian Recher, et al.
Blood|June 5, 2009
The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivoMarie-Pierre Gratacap, Valérie Martin, Marie-Cécile Valéra, et al.
American Journal of Clinical Oncology|June 1, 1992
Synchronous radiotherapy and chemotherapy with cisplatin in the management of locally advanced or recurrent head and neck cancerG Gasparini, G Recher, A Testolin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2026
Reversible superdeformability of hiPSC epithelial cortinoidsAnirban Jana, Justin Tauber, Adeline Boyreau, et al.
Haematologica|June 29, 2014
Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemiaThomas Prebet, Sarah Bertoli, Jacques Delaunay, et al.
Intensive Care Medicine|February 8, 2000
Changing use of intensive care for hematological patients: the example of multiple myelomaE Azoulay, C Recher, C Alberti, et al.
Annales De Dermatologie Et De Venereologie|January 22, 2021
Aggressive locoregional behavior of cutaneous squamous cell carcinoma during ruxolitinib useM Sauvage, S Tavitian, V Sibaud, et al.
Pageof 49

Showing results (211-220 of 488) with videos related to

Sort By:
Pageof 49
Neurology|September 26, 2002
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MSD Brassat, C Recher, E Waubant, et al.
Plos One|January 23, 2025
zIncubascope: Long-term quantitative imaging of multi-cellular assemblies inside an incubatorAnirban Jana, Naveen Mekhileri, Adeline Boyreau, et al.
Archives of Cardiovascular Diseases|December 3, 2014
Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal OccluderFrançois Godart, Ali Houeijeh, Morgan Recher, et al.
Blood|May 22, 2009
Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cellsAnnelies G Renner, Cédric Dos Santos, Christian Recher, et al.
Blood|June 5, 2009
The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivoMarie-Pierre Gratacap, Valérie Martin, Marie-Cécile Valéra, et al.
American Journal of Clinical Oncology|June 1, 1992
Synchronous radiotherapy and chemotherapy with cisplatin in the management of locally advanced or recurrent head and neck cancerG Gasparini, G Recher, A Testolin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2026
Reversible superdeformability of hiPSC epithelial cortinoidsAnirban Jana, Justin Tauber, Adeline Boyreau, et al.
Haematologica|June 29, 2014
Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemiaThomas Prebet, Sarah Bertoli, Jacques Delaunay, et al.
Intensive Care Medicine|February 8, 2000
Changing use of intensive care for hematological patients: the example of multiple myelomaE Azoulay, C Recher, C Alberti, et al.
Annales De Dermatologie Et De Venereologie|January 22, 2021
Aggressive locoregional behavior of cutaneous squamous cell carcinoma during ruxolitinib useM Sauvage, S Tavitian, V Sibaud, et al.
Pageof 49